Improving access to oral pre-exposure prophylaxis for HIV among international migrant populations
- PMID: 37421969
- DOI: 10.1016/S2468-2667(23)00105-6
Improving access to oral pre-exposure prophylaxis for HIV among international migrant populations
Abstract
Pre-exposure prophylaxis (PrEP) is recommended for people susceptible to HIV acquisition, and the scale-up of PrEP programmes has contributed to new HIV case reductions at a population level. However, international migrants continue to be disproportionately affected by HIV. Understanding barriers and facilitators to PrEP implementation among international migrants can optimise PrEP use among this population and ultimately reduce HIV incidence worldwide. We reviewed the evidence regarding factors influencing PrEP implementation among international migrants; 19 studies were included. The barriers and facilitators at the individual level were related to knowledge and risk perception of HIV. Cost, provider discriminations, and health system navigation influenced PrEP use at the service level. Positive or negative perception towards LGBT+ identities, HIV, and PrEP users affected PrEP use at the societal level. Most existing PrEP campaigns do not target international migrants; therefore, culturally tailored approaches for people from different backgrounds are warranted. Potentially migration-related and HIV-related discriminatory policies must be reviewed to increase access to HIV prevention services to end HIV transmission at a population level.
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests JJO has received funding from Gilead Sciences (Getting to 0 Grant to improve awareness and uptake of PrEP among overseas-born men who have sex with men in Australia). EPFC has received speaker's honoraria from MSD, CSL Seqirus, Roche, and Gilead Sciences, and investigator-initiated grants from MSD, outside the submitted work. BRB has received honoraria and research grants from Gilead Sciences and ViiV Healthcare, outside of the submitted work. AG received payments to his institution from ViiV Healthcare (grant and travel funding) and received fundings from GSK (for the gonorrhoea project), outside of the submitted work. All other authors declare no competing interests.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous